FibroGen (FGEN) Earnings Date & Reports

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FGEN is expected to report earnings to fall 280.00% to -9 cents per share on August 11

Q2'25

Est.

$-0.09

Q1'25

Beat

by $0.15

Q4'24

Beat

by $0.35

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.16

The last earnings report on May 13 showed earnings per share of 5 cents, beating the estimate of -10 cents. With 237.05K shares outstanding, the current market capitalization sits at 31.22M.

View a ticker or compare two or three

Compare

FGEN